<DOC>
	<DOC>NCT00909844</DOC>
	<brief_summary>The purpose of the protocol is to assess the efficacy of triptorelin 11.25 mg with respect to the proportion of children who maintain a regression or stabilisation of sexual maturity until the end of the study.</brief_summary>
	<brief_title>Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study</brief_title>
	<detailed_description />
	<mesh_term>Puberty, Precocious</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>The child must have completed study 25452014143 The child must have an effective response to 2 injections of triptorelin 11.25 mg according to investigator's evaluation with no significant treatment side effects The patient has a known hypersensitivity to any of the test materials or related compounds The patient is unable or unwilling to comply fully with the protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>